X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11262) 11262
Book Chapter (80) 80
Magazine Article (27) 27
Newsletter (25) 25
Publication (18) 18
Dissertation (9) 9
Newspaper Article (4) 4
Book / eBook (3) 3
Book Review (1) 1
Conference Proceeding (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7986) 7986
index medicus (4828) 4828
male (4428) 4428
female (4129) 4129
asthma (4083) 4083
administration, inhalation (3736) 3736
respiratory system (3514) 3514
inhaled corticosteroids (3460) 3460
asthma - drug therapy (2802) 2802
adult (2649) 2649
middle aged (2152) 2152
animals (1855) 1855
pharmacology & pharmacy (1658) 1658
child (1629) 1629
allergy (1562) 1562
treatment outcome (1538) 1538
adolescent (1464) 1464
corticosteroids (1457) 1457
immunology (1437) 1437
aged (1322) 1322
children (1312) 1312
pediatrics (1166) 1166
drug therapy (1143) 1143
therapy (1106) 1106
budesonide (1101) 1101
asthma - physiopathology (1070) 1070
dose-response relationship, drug (995) 995
inhaled nitric-oxide (986) 986
adrenal cortex hormones - administration & dosage (977) 977
care and treatment (950) 950
double-blind method (938) 938
inflammation (905) 905
double-blind (900) 900
anti-asthmatic agents - therapeutic use (881) 881
fluticasone propionate (876) 876
bronchodilator agents - administration & dosage (868) 868
fluticasone (853) 853
medicine, general & internal (834) 834
child, preschool (827) 827
research (808) 808
obstructive pulmonary-disease (777) 777
cardiac & cardiovascular systems (772) 772
risk factors (744) 744
chronic obstructive pulmonary disease (740) 740
efficacy (739) 739
adrenal cortex hormones - therapeutic use (733) 733
anti-asthmatic agents - administration & dosage (732) 732
health aspects (731) 731
pulmonary disease, chronic obstructive - drug therapy (731) 731
drug therapy, combination (728) 728
analysis (700) 700
critical care medicine (686) 686
salmeterol (684) 684
bronchodilator agents - therapeutic use (682) 682
inhalation (681) 681
time factors (654) 654
dosage and administration (650) 650
safety (632) 632
abridged index medicus (630) 630
mortality (626) 626
copd (620) 620
studies (597) 597
pulmonary hypertension (595) 595
nebulizers and vaporizers (585) 585
nitric oxide (577) 577
lung-function (575) 575
inhaled corticosteroid (573) 573
rats (559) 559
management (558) 558
airway inflammation (551) 551
asthma - diagnosis (551) 551
respiratory tract diseases (550) 550
infant, newborn (538) 538
toxicology (538) 538
mice (536) 536
severity of illness index (532) 532
exacerbations (525) 525
steroids (517) 517
infant (514) 514
drug administration schedule (513) 513
aerosols (505) 505
forced expiratory volume (498) 498
risk (487) 487
medicine & public health (478) 478
respiratory function tests (476) 476
glucocorticoids - administration & dosage (472) 472
hypertension, pulmonary - drug therapy (470) 470
young adult (470) 470
lung diseases, obstructive (461) 461
pharmacokinetics (457) 457
retrospective studies (454) 454
androstadienes - administration & dosage (441) 441
childhood asthma (439) 439
lung - drug effects (439) 439
patients (439) 439
adults (434) 434
anti-inflammatory agents - administration & dosage (433) 433
clinical trials (433) 433
prospective studies (428) 428
randomized controlled trials as topic (428) 428
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11165) 11165
French (98) 98
Japanese (82) 82
German (66) 66
Spanish (44) 44
Russian (14) 14
Portuguese (8) 8
Italian (5) 5
Polish (5) 5
Korean (4) 4
Chinese (3) 3
Lithuanian (2) 2
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 20, pp. 1877 - 1887
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, p. CD002311
Background Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36 weeks postmenstrual age (PMA), remains an important complication of... 
Budesonide | Pneumonia | Respiratory Disorders | Dexamethasone | Glucocorticoids | Administration, Inhalation | Bronchopulmonary Dysplasia | Fluticasone | Randomized Controlled Trials as Topic | Beclomethasone | Neonatal care | Infant, Premature | Child health | Anti‐Inflammatory Agents | Fluocinolone Acetonide | Bronchopulmonary Dysplasia (Chronic Lung Disease) | Medicine General & Introductory Medical Sciences | CONTROLLED-TRIAL | INHALED GLUCOCORTICOID THERAPY | LOW-BIRTH-WEIGHT | Humans | PREMATURE-INFANTS | Infant | CHRONIC LUNG-DISEASE | MEDICINE, GENERAL & INTERNAL | Anti-Inflammatory Agents [administration & dosage] | Dexamethasone [administration & dosage] | Bronchopulmonary Dysplasia [etiology | Glucocorticoids [administration & dosage] | drug therapy | Budesonide [administration & dosage] | prevention& control | ADRENAL-FUNCTION | BECLOMETHASONE DIPROPIONATE | Beclomethasone [administration & dosage] | Pneumonia [complications | METERED-DOSE INHALER | Newborn | Androstadienes [administration & dosage] | FLUTICASONE PROPIONATE | analogs & derivatives | DOUBLE-BLIND | Fluocinolone Acetonide [administration & dosage | Beclomethasone - administration & dosage | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Dexamethasone - administration & dosage | Fluocinolone Acetonide - analogs & derivatives | Bronchopulmonary Dysplasia - prevention & control | Pneumonia - drug therapy | Fluticasone - administration & dosage | Pneumonia - complications | Anti-Inflammatory Agents - administration & dosage | Budesonide - administration & dosage | Bronchopulmonary Dysplasia - etiology | Infant, Newborn
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2010, Volume 362, Issue 11, pp. 975 - 985
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2010, Issue 5, p. CD005535
.... Selection criteria We included RCTs if they compared the addition of inhaled LABAs versus placebo to the same dose of ICS in children aged two years and above and in adults... 
Formoterol Fumarate | Lungs & airways | Adrenal Cortex Hormones | Asthma (chronic): bronchodilators | Anti‐Asthmatic Agents | Combination and additive therapies | Beclomethasone | Asthma (chronic) | Child health | Bronchodilators | Asthma, chronic ‐ pharmacotherapy | Albuterol | Drug Therapy, Combination | Asthma (chronic): combination/additive drug treatment | Salmeterol Xinafoate | Administration, Inhalation | Ethanolamines | Asthma | Randomized Controlled Trials as Topic | Steroids, inhaled | Beta‐agonists, long‐acting | Adrenergic beta‐Agonists | Medicine General & Introductory Medical Sciences | Chronic Disease | Combination/additive drug treatment | Adrenal Cortex Hormones [therapeutic use] | COST-EFFECTIVENESS ANALYSIS | Humans | Adrenergic beta-Agonists [therapeutic use] | SURROGATE INFLAMMATORY MARKERS | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE/SALMETEROL COMBINATION | LEUKOTRIENE RECEPTOR ANTAGONIST | Asthma [drug therapy] | Adult | TWICE-DAILY TREATMENT | SALMETEROL/FLUTICASONE PROPIONATE COMBINATION | FORMOTEROL OXIS(R) TURBUHALER(R) | QUALITY-OF-LIFE | MILD PERSISTENT ASTHMA | Child | Anti-Asthmatic Agents [therapeutic use] | ONCE-DAILY BUDESONIDE | Beclomethasone - administration & dosage | Albuterol - analogs & derivatives | Child, Preschool | Asthma - drug therapy | Ethanolamines - administration & dosage | Drug Therapy, Combination - methods | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Anti-Asthmatic Agents - administration & dosage | Adrenal Cortex Hormones - administration & dosage
Journal Article
Circulation, ISSN 0009-7322, 07/2013, Volume 128, Issue 5, pp. 502 - 511
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2016, Issue 1, p. CD009878
.... Their potential for growth suppression remains a matter of concern for parents and physicians. Objectives To assess whether increasing the dose of ICS is associated with slower linear growth, weight gain and skeletal maturation in children with asthma... 
Pregnadienediols | Budesonide | Pregnenediones | Lungs & airways | Growth | Adrenal Cortex Hormones | Androstadienes | Administration, Inhalation | Anti‐Asthmatic Agents | Fluticasone | Asthma | Randomized Controlled Trials as Topic | Asthma (chronic): corticosteroids | Dose‐Response Relationship, Drug | Steroids, inhaled | Beclomethasone | Asthma (chronic) | Child health | Mometasone Furoate | Asthma, chronic ‐ pharmacotherapy | Growth Disorders | Medicine General & Introductory Medical Sciences | Corticosteroids (inhaled, oral or intranasal) | BUDESONIDE INHALATION SUSPENSION | ONCE-DAILY CICLESONIDE | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE | COLLAGEN TURNOVER | IMPROVES LUNG-FUNCTION | LONG-TERM SAFETY | MOMETASONE FUROATE | BECLOMETHASONE DIPROPIONATE AEROSOL | EXHALED NITRIC-OXIDE | CHILDHOOD ASTHMA | Anti-Asthmatic Agents - adverse effects | Beclomethasone - administration & dosage | Growth Disorders - chemically induced | Humans | Pregnenediones - administration & dosage | Pregnadienediols - administration & dosage | Asthma - drug therapy | Pregnenediones - adverse effects | Dose-Response Relationship, Drug | Growth - drug effects | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Pregnadienediols - adverse effects | Budesonide - adverse effects | Beclomethasone - adverse effects | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Androstadienes - adverse effects | Child | Adrenal Cortex Hormones - administration & dosage
Journal Article
Expert Review of Respiratory Medicine, ISSN 1747-6348, 06/2014, Volume 8, Issue 3, pp. 357 - 379
...) are recommended therapies in the management of chronic obstructive pulmonary disease (COPD). Three fixed-dose combination products have recently been approved for the treatment of COPD (the long-acting... 
patient-reported outcomes | lung function | combination therapy | long-acting bronchodilators | chronic obstructive pulmonary disease | exacerbation | inhaled corticosteroids | FLUTICASONE FUROATE/VILANTEROL | IMPROVES LUNG-FUNCTION | MU-G | OBSTRUCTIVE PULMONARY-DISEASE | ONCE-DAILY QVA149 | RESPIRATORY SYSTEM | DRY-POWDER INHALER | DELIVERY CHARACTERISTICS | DOUBLE-BLIND | CARDIOVASCULAR SAFETY | BRONCHODILATOR THERAPY | Formoterol Fumarate | Salmeterol Xinafoate | Bronchodilator Agents - administration & dosage | Humans | Albuterol - analogs & derivatives | Benzyl Alcohols - administration & dosage | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Ethanolamines - administration & dosage | Quinuclidines - administration & dosage | Disease Progression | Chlorobenzenes - administration & dosage | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Disease Management | Indans - administration & dosage | Drug Combinations | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Tiotropium Bromide
Journal Article